Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
Titel:
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
Auteur:
Stein, Eytan M. DiNardo, Courtney D. Fathi, Amir T. Mims, Alice S. Pratz, Keith W. Savona, Michael R. Stein, Anthony S. Stone, Richard M. Winer, Eric S. Seet, Christopher S. Döhner, Hartmut Pollyea, Daniel A. McCloskey, James K. Odenike, Olatoyosi Löwenberg, Bob Ossenkoppele, Gert J. Patel, Prapti A. Roshal, Mikhail Frattini, Mark G. Lersch, Frederik Franovic, Aleksandra Nabhan, Salah Fan, Bin Choe, Sung Wang, Hongfang Wu, Bin Hua, Lei Almon, Caroline Cooper, Michael Kantarjian, Hagop M. Tallman, Martin S.